MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1038/s41573-026-01496-2

Медицинская библиотека · Nature reviews. Drug discovery · 2026

Artificial intelligence in drug discovery - what it is, where we stand and the path forward.

Bender Andreas, Thomas Morgan C, Scannell Jack W, Shaywitz David A, Ghiandoni Gian Marco, Greener Joe G, Pruteanu Lavinia-Lorena, Jacobson Rachel DeVay, Handa Koichi, Hirano Mariko, Seal Srijit, Mahale Manas, Schmidt Marco F, Ahfeldt Tim, Grisoni Francesca, Cortes-Ciriano Isidro

СтатьяОбзорПеревод в очереди

Аннотация

Artificial intelligence (AI) in drug discovery has attracted increasing interest over the past decade. It is now time for a critical review of progress in the field: where did we advance - and where are we yet to see impact - when it comes to what matters in drug discovery, which is to deliver safer and more efficacious medicines to patients faster? Although a wide variety of AI methods have been developed, applied and benchmarked, evidence of their clinically relevant impact is, so far, disappointingly limited. In this Perspective we discuss potential reasons, including an insufficient focus on clinical translation during model development, difficulties with applying AI algorithms on conditional life science data, and insufficient problem definitions and the resulting underspecification of computational models for real-world use cases. 'Technology push' compared with 'science pull' is also likely to be an underlying factor, as well as the substantial time required to operationalize technical capabilities into systems that are sufficiently scaled and accessible for users. We provide recommendations for the development of AI in drug discovery with the aim of increasing its translational relevance. For example, benchmarking studies of AI tools in drug discovery need to move on from model validation and instead focus on their ability to improve decision making.

Для цитирования: Bender Andreas, Thomas Morgan C, Scannell Jack W, Shaywitz David A, Ghiandoni Gian Marco, Greener Joe G, Pruteanu Lavinia-Lorena, Jacobson Rachel DeVay, Handa Koichi, Hirano Mariko, Seal Srijit, Mahale Manas, Schmidt Marco F, Ahfeldt Tim, Grisoni Francesca, Cortes-Ciriano Isidro. Artificial intelligence in drug discovery - what it is, where we stand and the path forward.. Nature reviews. Drug discovery. 2026. DOI: 10.1038/s41573-026-01496-2.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.